Evidence map›Paper›PMID 25726559›Full record

ReviewEuropean respiratory review : an official journal of the European Respiratory Society2015

Host-microbe interactions in distal airways: relevance to chronic airway diseases.

Clémence Martin, Pierre-Régis Burgel, Patricia Lepage, Claire Andréjak, Jacques de Blic, Arnaud Bourdin, Jacques Brouard, Pascal Chanez, Jean-Charles Dalphin, Gaetan Deslée and 4 more

Open access · diamondAbstract readReview
In one paragraph

Review in European respiratory review : an official journal of the European Respiratory Society, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
8.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it, 43 citations in OpenAlex.

  1. The effect of mTOR inhibitors on respiratory infections in lymphangioleiomyomatosis.European respiratory review : an official journal of the European Respiratory Society · 2017
    Pooled it
  2. Antibacterial and Antibiofilm Activity ofJournal of fungi (Basel, Switzerland) · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. A Review on the Nasal Microbiome and Various Disease Conditions for Newer Approaches to Treatments.Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India · 2023
    Article
  8. Interstitial Lung Disease in Immunocompromised Children.Diagnostics (Basel, Switzerland) · 2022
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 13 institutions in 1 country.

Clémence MartinHôpital Cochin, AP-HP, Université Paris Descartes, Sorbonne Paris Cité, Paris, France.
Pierre-Régis BurgelHôpital Cochin, AP-HP, Université Paris Descartes, Sorbonne Paris Cité, Paris, France pierre-regis.burgel@cch.aphp.fr.
Patricia LepageUMR1913-Microbiologie de l'Alimentation au Service de la Santé, l'Institut National de la Recherche Agronomique, Jouy-en-Josas, France.
Claire AndréjakRespiratory Intensive Care Unit, Centre Hospitalier Universitaire Sud, Amiens, France.
Jacques de BlicHôpital Necker-Enfants Malades, AP-HP, Université Paris Descartes, Paris, France.
Arnaud BourdinHôpital Arnaud de Villeneuve, CHU Montpellier, Montpellier, France.
Jacques BrouardDept of Pediatrics, CHU de Caen, Research Unit EA 4655 U2RM, Caen, France.
Pascal ChanezDépt des Maladies Respiratoires, AP-HM, Laboratoire d'immunologie INSERM CNRS U 1067, UMR 7733, Aix Marseille Université, Marseille, France.
Jean-Charles DalphinHôpital Jean Minjoz, Besançon, France.
Gaetan DesléeDept of Pulmonary Medicine, University Hospital of Reims, Reims, France.
Antoine DeschildreHôpital Jeanne de Flandres, CHRU de Lille, Lille, France.
Philippe GossetUnité de défense innée et inflammation, Institut Pasteur, Paris, France INSERM U874, Paris, France.
Lhousseine TouquiInstitut Pasteur de Lille, Centre d'Infection et d'Immunité de Lille, Lille, France.
Daniel DusserHôpital Cochin, AP-HP, Université Paris Descartes, Sorbonne Paris Cité, Paris, France.
Assistance Publique – Hôpitaux de Paris · FRCenter for Infection and Immunity of Lille · FRCentre Hospitalier Universitaire Amiens-Picardie · FRCentre Hospitalier Universitaire de Lille · FRCentre National de la Recherche Scientifique · FRDélégation Paris 5 · FRHôpital Arnaud de Villeneuve · FRHôpital Necker-Enfants Malades · FRHôpital Privé Jean Mermo · FRInstitut Pasteur · FRMicrobiologie de l’alimentation au service de la santé · FRUniversité de Caen Normandie · FRUniversité de Reims Champagne-Ardenne · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This article is the summary of a workshop, which took place in November 2013, on the roles of microorganisms in chronic respiratory diseases. Until recently, it was assumed that lower airways were sterile in healthy individuals. However, it has long been acknowledged that microorganisms could be identified in distal airway secretions from patients with various respiratory diseases, including cystic fibrosis (CF) and non-CF bronchiectasis, chronic obstructive pulmonary disease, asthma and other chronic airway diseases (e.g. post-transplantation bronchiolitis obliterans). These microorganisms were sometimes considered as infectious agents that triggered host immune responses and contributed to disease onset and/or progression; alternatively, microorganisms were often considered as colonisers, which were considered unlikely to play roles in disease pathophysiology. These concepts were developed at a time when the identification of microorganisms relied on culture-based methods. Importantly, the majority of microorganisms cannot be cultured using conventional methods, and the use of novel culture-independent methods that rely on the identification of microorganism genomes has revealed that healthy distal airways display a complex flora called the airway microbiota. The present article reviews some aspects of current literature on host-microbe (mostly bacteria and viruses) interactions in healthy and diseased airways, with a special focus on distal airways.

Indexed as

Host-Pathogen InteractionsAsthmaBronchiectasisCystic FibrosisGastrointestinal MicrobiomeHumansLungMicrobiotaMycobacteriumPulmonary Disease, Chronic ObstructiveRespiratory Tract Diseases

Identifiers

PMID25726559
PMCPMC9487770
OpenAlexW2148406307

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.